Myelin-Oligodendrocyte Glycoprotein
"Myelin-Oligodendrocyte Glycoprotein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A transmembrane protein present in the MYELIN SHEATH of the CENTRAL NERVOUS SYSTEM. It is one of the main autoantigens implicated in the pathogenesis of MULTIPLE SCLEROSIS.
| Descriptor ID |
D063308
|
| MeSH Number(s) |
D12.776.395.550.114.500 D12.776.543.550.195.500 D12.776.543.620.550 D12.776.631.580.530 D23.050.422.625
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Myelin-Oligodendrocyte Glycoprotein".
Below are MeSH descriptors whose meaning is more specific than "Myelin-Oligodendrocyte Glycoprotein".
This graph shows the total number of publications written about "Myelin-Oligodendrocyte Glycoprotein" by people in this website by year, and whether "Myelin-Oligodendrocyte Glycoprotein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 3 | 3 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 4 | 4 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 2 | 2 |
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 1 | 1 |
| 2016 | 3 | 0 | 3 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 2 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 2 | 2 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myelin-Oligodendrocyte Glycoprotein" by people in Profiles.
-
Azizi G, Van den Broek B, Ishikawa LLW, Naziri H, Yazdani R, Zhang GX, Ciric B, Rostami A. IL-7Ra on CD4+ T cells is required for their survival and the pathogenesis of experimental autoimmune encephalomyelitis. J Neuroinflammation. 2024 Oct 08; 21(1):253.
-
Stathopoulos P, Dalakas MC. The role of complement and complement therapeutics in neuromyelitis optica spectrum disorders. Expert Rev Clin Immunol. 2022 09; 18(9):933-945.
-
Zehden J, Harish Bindiganavile S, Bhat N, Lee AG, Avery R, Golnik KC. Delayed Diagnosis of Anti-Myelin Oligodendrocyte Glycoprotein One Decade After Presumed Recurrent Acute Disseminated Encephalomyelitis. J Neuroophthalmol. 2022 06 01; 42(2):e469-e472.
-
Kornbluh AB, Liu GT, Hopkins SE. Delayed Visual Improvement in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis. Pediatr Neurol. 2022 01; 126:43-45.
-
Younes S, Sigireddi RR, Raviskanthan S, Mortensen PW, Lee AG. Bilateral myelin oligodendrocyte glycoprotein-related optic neuritis presenting after herpes zoster subunit vaccination. Can J Ophthalmol. 2021 10; 56(5):e157-e160.
-
Casella G, Rasouli J, Boehm A, Zhang W, Xiao D, Ishikawa LLW, Thome R, Li X, Hwang D, Porazzi P, Molugu S, Tang HY, Zhang GX, Ciric B, Rostami A. Oligodendrocyte-derived extracellular vesicles as antigen-specific therapy for autoimmune neuroinflammation in mice. Sci Transl Med. 2020 11 04; 12(568).
-
Thome R, Bonfanti AP, Rasouli J, Mari ER, Zhang GX, Rostami A, Verinaud L. Chloroquine-treated dendritic cells require STAT1 signaling for their tolerogenic activity. Eur J Immunol. 2018 07; 48(7):1228-1234.
-
Gaspar MP, Landes G, Safavi F, Osterman AL. Accidental Injection of Freund Complete Adjuvant With Mycobacterium Tuberculosis. J Hand Surg Am. 2018 09; 43(9):873.e1-873.e4.
-
Zhou F, Zhang GX, Rostami A. LPS-treated bone marrow-derived dendritic cells induce immune tolerance through modulating differentiation of CD4+ regulatory T cell subpopulations mediated by 3G11 and CD127. Immunol Res. 2017 06; 65(3):630-638.
-
Wang L, Li Z, Ciric B, Safavi F, Zhang GX, Rostami A. Selective depletion of CD11c+ CD11b+ dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE. Eur J Immunol. 2016 10; 46(10):2454-2466.